Sharechat Logo

Daily ShareChat: Fisher & Paykel Healthcare

By Jenny Ruth

Thursday 26th November 2009

Text too small?
 Jenny Ruth

Fisher & Paykel Healthcare's underlying performance remains strong despite a currency-related downgrade in earnings, says Forsyth Barr analyst Guy Hallwright.

The company has changed its currency assumption from 67 US cents to 74 cents for its second half and cut its earnings guidance by $10 million to between $65 million and $70 million.

"Guidance at the beginning of the year assumed a 60 cents rate, which would imply a $25 million to $30 million downgrade," Hallwright says. "A revision of only $10 million indicates that the underlying buisiness is performing better than expected."

Fisher & Paykel's first-half net profit rose 31% to $37 million.

The company has a strong growth outlook in both its obstructive sleep apnoea business (whose underlying sales rose 20% in the first half) and its respiratory and acute care products (whose first-half sales were up 14%, adjusted for $10 million in one-off sales), Hallwright says.

Expansion into new segments could potentially triple the company's addressable market, he says.

Still, Fisher & Paykel shares already trade on fairly high multiples and a lower currency is needed for the shares to perform strongly from here, he says. Hallwright is expecting a strong New Zealand dollar will persist through 2011. "With less hedging in place, this will impact profits."

BROKER CALL:  Forsyth Barr rate FPH as accumulate.

 



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZ dollar rally may limit profit gains for Fisher and Paykel Healthcare, brokerage says
FISHER & PAYKEL HEALTHCARE ANNOUNCES NEW NASAL PILLOWS MASK AT INVESTOR DAY
Shares in Fisher and Paykel Healthcare third-best performer on NZX 50 after raising earnings forecast
Fisher and Paykel Healthcare raises 2014 earnings forecast on higher sales, margins
F and P Healthcare shares jump to highest in more than 2 years on profit outlook
F and P Healthcare beats 2013 guidance, forecasts boost in 2014 profit; shares gain to 2 1/2 year high
F and P Healthcare shares rise to two-year high as First NZ raises rating on better outlook
Fisher & Paykel Healthcare
F and P Healthcare lifts guidance as sales grow, margins widen; shares rally
F&P Healthcare 1H profit rises 18%, on record sales, wider margins